Table 2 AI system diagnostic accuracy

From: Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices

 

Point estimate

95% CI

Superiority endpoint

Sensitivity

87.2%

81.8%–91.2%

85.0%

Specificity

90.7%

88.3%–92.7%

82.5%

  1. Point estimates for sensitivity and specificity were calculated on the 819 participants that were analyzable, using the prespecified logistic regression. The superiority endpoints were previously discussed with FDA.